New Era Energy & Digital (Nasdaq: NUAI) and its JV partner Sharon AI have locked in 203 additional contiguous acres for their Texas Critical Data Centers (TCDC) project, expanding the total site to 438 acres. Strategically located near key infrastructure, the expanded footprint supports scalable development of a multi-phase, multi-gigawatt AI and high-performance computing (HPC) campus—positioning TCDC as a cornerstone of New Era’s vertically integrated platform for next-gen compute and power infrastructure.

NioCorp Developments (Nasdaq: NB) will host U.S. Senator Pete Ricketts at its Dec. 5 Town Hall Dinner in Elk Creek, Nebraska, highlighting growing federal support for the Company’s Elk Creek Project—a major U.S. source of niobium, scandium, titanium, and potentially rare earths. Governor Jim Pillen will headline the afternoon session, as NioCorp updates stakeholders on its progress toward becoming a key domestic supplier of critical minerals essential for defense, clean energy, and advanced manufacturing.

NDT Pharmaceuticals (OTC: NDTP) subsidiary Good Salt™ Life has secured a major contract with the Tennessee Department of Correction, deploying its proprietary biosafety system—including Clean Republic HOCl disinfectant and ByoCart Sprayer units—across state prisons. The $300K initial deal is expected to yield multi-year recurring revenue and marks a pivotal expansion into the institutional market, reinforcing the company’s eco-friendly, non-toxic approach to infection control in high-security environments.

FibroBiologics (Nasdaq: FBLG) has fully repaid its outstanding convertible promissory notes with Yorkville, eliminating potential dilution and bolstering its balance sheet ahead of key clinical milestones. With the SEPA still in place for up to $10M in future equity funding, the company is now focused on advancing fibroblast-based therapeutics, including CYWC628 for diabetic foot ulcers, slated for Phase 1/2 trials in early 2026.